Adjuvant BCG immunotherapy for malignant melanoma.

A total of 199 patients with stage I malignant melanoma at Clark's level 3 to 5 of invasion were entered into a prospectively controlled randomized clinical trial that attempted to assess the value of local and systemic immunotherapy with BCG (bacille Calmette-Guérin) after surgery. The patient...

Full description

Saved in:
Bibliographic Details
Main Authors: Paterson, A H, Willans, D J, Jerry, L M, Hanson, J, McPherson, T A
Format: Artigo
Language:Inglês
Published: 1984
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1483595/
https://ncbi.nlm.nih.gov/pubmed/6383591
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items